MiMedx Group competitors

MiMedx Group Competitors include Synoste, Bonesupport, Fuse Medical and Gecko Biomedical.

Add company...

Save Comparison Clear all	MiMedx Group MiMedx Group is a distributor and marketer of innovative bioactive healing products for tissue regeneration.	Synoste Synoste is a startup company that develops medical solutions to treat skeletal deformities.	Bonesupport Bonesupport develops and commercializes injectable bio-ceramic bone graft substitutes for the treatment of bone voids.	Fuse Medical Fuse Medical is engaged in the distribution of medical devices, supplies, and surgical solutions.	Gecko Biomedical Gecko Biomedical develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Founding Date	Founding Date 2008	Founding Date 2012	Founding Date 1999	Founding Date 2012	Founding Date 2013
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare Retail biotech distribution surgical solutions	Tags Healthcare surgical solutions	Tags Healthcare biotech medical diagnostics medtech surgical solutions	Tags Healthcare distribution medical devices surgical solutions	Tags Healthcare biotech chemicals surgical solutions
Locations	Locations Marietta, US HQ	Locations Espoo, FI HQ Düsseldorf, DE	Locations Lund, SE HQ	Locations Fort Worth, US HQ	Locations Paris, FR HQ Paris, FR
Employees	Employees 690	Employees 14	Employees 64	Employees 2	Employees 44
Valuation ($)	Valuation ($) 406.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 39.7 m	Valuation ($) N/A
Twitter followers	Twitter followers 410	Twitter followers N/A	Twitter followers N/A	Twitter followers N/A	Twitter followers 470
Financial ⚠
Revenue (est.)	Revenue (est.) $245m (FY, 2016)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $26.4m (FY, 2017)	Revenue (est.) N/A
Cost of goods	Cost of goods $32.4m (FY, 2016)	Cost of goods N/A	Cost of goods N/A	Cost of goods $14.6m (FY, 2017)	Cost of goods N/A
Gross profit	Gross profit $212.6m (FY, 2016)	Gross profit N/A	Gross profit N/A	Gross profit $11.8m (FY, 2017)	Gross profit N/A
Net income	Net income $12m (FY, 2016)	Net income N/A	Net income N/A	Net income $699.7k (FY, 2017)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 5.9m (4 months ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 1.6m (over 2 years ago)
Total funding raised	Total funding raised $ 36.8m	Total funding raised $ 11.8m	Total funding raised $ 110.3m	Total funding raised N/A	Total funding raised $ 39m